Exactech Inc (EXAC) 26.30 $EXAC Exactech Up 32.7% Since

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 9:04 PM

Exactech Inc (EXAC) 26.30 $EXAC

Exactech Up 32.7% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Mon Jun 20, 1:03PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 3 months, Exactech has returned 32.68% as of today's recent price of $26.55.
EXAC: 26.30 (+0.18)

Exactech Expands Competency in 3-D Printing with Purchase of Arcam Q10plus Systems
BusinessWire - Thu Jun 16, 8:00AM CDT
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this week to expand its in-house manufacturing capabilities. This investment will advance Exactech's long-term commitment to additive manufacturing technology, also known as 3-D printing.
EXAC: 26.30 (+0.18)

Exactech (EXAC) Scales a 52-Week High on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:58AM CDT
Share price of Exactech Inc (EXAC) reached a new 52-week high of $25.86 on Jun 14.
IRMD: 21.48 (+0.14), MASI: 52.38 (+0.69), EXAC: 26.30 (+0.18), CRY: 11.94 (+0.09)

Exactech Has Returned 26.6% Since SmarTrend Recommendation (EXAC)
Comtex SmarTrend(R) - Fri Jun 10, 1:24PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 26.59% as of today's recent price of $25.33.
EXAC: 26.30 (+0.18)

DENTSPLY (XRAY) Scales a 52-Week High on Strong Q1 Results
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 6:02AM CDT
Shares of DENTSPLY International Inc. (XRAY) rallied to a new 52-week high of $64.59 on Jun 9.
IRMD: 21.48 (+0.14), MASI: 52.38 (+0.69), EXAC: 26.30 (+0.18), XRAY: 64.21 (+0.74)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive (Revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 3:37AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations.
IRMD: 21.48 (+0.14), MASI: 52.38 (+0.69), TROV: 4.80 (+0.22), EXAC: 26.30 (+0.18)

Exactech and University of Florida Expand Partnership, Promote Health Education with Naming of "Exactech Arena" at the Stephen C. O'Connell Center
BusinessWire - Thu Jun 09, 3:59PM CDT
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today an expansion of its long-standing partnership with the University of Florida (UF) through naming of Exactech Arena at the newly remodeled Stephen C. O'Connell Center, a sports and entertainment complex on the university's campus.
EXAC: 26.30 (+0.18)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:39AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations in the urine of patients with non-small cell lung cancer (NSCLC).
IRMD: 21.48 (+0.14), MASI: 52.38 (+0.69), TROV: 4.80 (+0.22), EXAC: 26.30 (+0.18)

Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 36.55 (+0.89), MASI: 52.38 (+0.69), EXAC: 26.30 (+0.18), CRY: 11.94 (+0.09)

Exactech Up 24.9% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Fri Jun 03, 1:04AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 24.89% as of today's recent price of $24.99.
EXAC: 26.30 (+0.18)

Inogen (INGN) Introduces Next-Gen Inogen One G4 POC
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:15AM CDT
Inogen Inc (INGN) recently launched a next-generation portable oxygen concentrator (POC) -- Inogen One G4.
MASI: 52.38 (+0.69), INGN: 47.45 (+2.56), EXAC: 26.30 (+0.18), CRY: 11.94 (+0.09)

Shares of EXAC Up 21.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 26, 1:34PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 21.24% as of today's recent price of $24.26.
EXAC: 26.30 (+0.18)

Cynosure (CYNO) Up on FDA Approval for New 1064nm LDS
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:44AM CDT
Cynosure Inc. (CYNO) recently announced the receipt of FDA approval for marketing a new Laser Delivery System (LDS) for PicoSure.
IRMD: 21.48 (+0.14), MASI: 52.38 (+0.69), CYNO: 48.19 (+0.36), EXAC: 26.30 (+0.18)

22.3% Return Seen to Date on SmarTrend Exactech Call (EXAC)
Comtex SmarTrend(R) - Thu May 19, 1:28AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 22.29% as of today's recent price of $24.47.
EXAC: 26.30 (+0.18)

TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:16AM CDT
TrovaGene Inc (TROV) reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year-ago loss of 33 cents.
TROV: 4.80 (+0.22), TECH: 112.74 (+1.55), EXAC: 26.30 (+0.18), NVRO: 74.10 (+4.07)

Exactech Inc. (Nasdaq: EXAC) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Mon May 02, 9:00AM CDT
What:
EXAC: 26.30 (+0.18), NDAQ: 64.41 (+1.32)

Exactech Celebrates 20-Year Nasdaq Listing Anniversary
BusinessWire - Mon May 02, 8:00AM CDT
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today that in honor of the company's 20th anniversary of its Nasdaq listing, Exactech founders Bill Petty, MD, Betty Petty and Gary Miller, PhD, will ring the Nasdaq Closing Bell on Tuesday, May 3. The ceremony will take place from 3:45 - 4:00 p.m. ET at Nasdaq MarketSite in Times Square, New York.
EXAC: 26.30 (+0.18)

DexCom (DXCM) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:46AM CDT
Shares of DexCom Inc. (DXCM) fell 3.6% to close at $65.96 on Apr 28, following a disappointing first-quarter 2016 earnings release.
ANTM: 128.67 (-0.05), DXCM: 77.59 (+0.10), INGN: 47.45 (+2.56), EXAC: 26.30 (+0.18)

Varian (VAR) Beats Q2 Earnings by a Penny, Lags Revenues
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:19AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.09 per share in the second quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a penny.
RTIX: 3.80 (+0.07), VAR: 84.31 (+1.23), INGN: 47.45 (+2.56), EXAC: 26.30 (+0.18)

Accuray (ARAY) Posts Earnings in Q3, Down on View Cut
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:55AM CDT
Shares of Accuray Inc. (ARAY) fell 3.3% in after-hours trading following the company's third-quarter fiscal 2016 results and trimmed fiscal 2016 guidance.
INGN: 47.45 (+2.56), EXAC: 26.30 (+0.18), ARAY: 5.26 (+0.13), HOLX: 35.62 (+1.51)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unlocking Airbnb Success: Expert Tips on Design Features

Design's Role in Capturing Airbnb Guests Alright, folks, let's dissect what really gets those Airbnb bookings. Wendy Anguiano, no stranger to sprucing up coastal rentals, dishes the dirt on design elements that scream 'book me' on first click. She's hailed from Design & Dwell Homes, operating right from the heart of Santa Rosa Beach, Florida. It's a fierce market out...

oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Scania's Q3 Results: A Resilient Yet Uneven Ride

Scania Steadies the Ship in Q3 with Robust Growth Sailing through a patchy global market, Swedish powerhouse Scania's latest quarterly figures reflect a mixed bag of results. Their performance in this third quarter of 2026 stood strong, despite some wobbles. The company showed resilience in sales and profitability, with numbers telling a tale that's a bit like a truck...

Nakama's AniBiz Gains Power with New Investments

Anime Titans Back AniBiz Think of the anime sector with a new sheriff in town, and its name is AniBiz.com. This platform, a brainchild of Nakama, Inc., just landed strategic investments from some heavyweight players in the anime world: TBS Group, Toei Animation, and TV TOKYO Holdings. The Significance of Strategic Support Ain’t no small potatoes here. We're talking the...

transcosmos & Metaverse Creators to Boost VRChat Content

Charting the Course for Global VR Expansion transcosmos and Metaverse Creators are throwing down the gauntlet to the barriers between Japanese VR magic and the global market. They're teaming up to sling 3D content from creators in Japan straight to users worldwide via Geek Jack, a cross-border e-commerce bridge built for entertainment. You can't deny it—VRChat's allure...

AppGate Rises as 2026 Leader in Digital Risk

AppGate: Forging a Path in Digital Security In a world where cyber threats seem to lurk around every digital corner, snagging the title of a leader in digital risk protection from the SPARK Matrix is no small feat. Let’s dive deep into AppGate’s rise to the top in QKS Group’s 2026 evaluation. What Sets AppGate Apart? AppGate's leadership status isn't some overnight...

Greentown Labs Builds Momentum in Climate Innovation

Paving the Way for Climate-Tech Pioneers Ah, Massachusetts—where the perfect storm of bright minds and groundbreaking innovation is brewing. It's not all just Harvard and MIT. It's programs like Greentown Labs' First Valley Fellowship stirring the pot, ushering in a new era of climate and energy startups. We're talking a robust second year for the Fellowship, where...

Antibiotic Overuse for Sinus Infections Costs Billions

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Goodyear Appoints Jerome Rouquet as New CFO

Shift Gears: New CFO at Goodyear In the latest bend of the corporate track, Goodyear Tire & Rubber Company, known to Wall Street as NASDAQ:GT, has announced a big shift in its financial crew. They've tapped Jerome Rouquet to be the chief financial officer starting December 1, 2026. This ain't your routine change—it's a strategic play straight from the pit stop as...

Infotech's 2027 Trends: AI Reshapes Strategy & Risk

AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...